Rutgeerts P - Search Results

1

Neutrophil gelatinase B-associated lipocalin and matrix metalloproteinase-9 complex as a surrogate serum marker of mucosal healing in ulcerative colitis.

de Bruyn M, Arijs I, Wollants WJ, Machiels K, Van Steen K, Van Assche G, Ferrante M, Rutgeerts P, Vermeire S, Opdenakker G. de Bruyn M, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2014 Jul;20(7):1198-207. doi: 10.1097/MIB.0000000000000068. Inflamm Bowel Dis. 2014. PMID: 24871805

2

Long-Term Outcome of Patients with Ulcerative Colitis and Primary Non-response to Infliximab.

Papamichael K, Rivals-Lerebours O, Billiet T, Vande Casteele N, Gils A, Ferrante M, Van Assche G, Rutgeerts PJ, Mantzaris GJ, Peyrin-Biroulet L, Vermeire S. Papamichael K, et al. J Crohns Colitis. 2016 Sep;10(9):1015-23. doi: 10.1093/ecco-jcc/jjw067. Epub 2016 Mar 28. J Crohns Colitis. 2016. PMID: 27022161

3

Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis.

Arts J, D'Haens G, Zeegers M, Van Assche G, Hiele M, D'Hoore A, Penninckx F, Vermeire S, Rutgeerts P. Arts J, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2004 Mar;10(2):73-8. doi: 10.1097/00054725-200403000-00002. Inflamm Bowel Dis. 2004. PMID: 15168804

4

C-reactive protein as a marker for inflammatory bowel disease.

Vermeire S, Van Assche G, Rutgeerts P. Vermeire S, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2004 Sep;10(5):661-5. doi: 10.1097/00054725-200409000-00026. Inflamm Bowel Dis. 2004. PMID: 15472532 Review.

5

Predictors of early response to infliximab in patients with ulcerative colitis.

Ferrante M, Vermeire S, Katsanos KH, Noman M, Van Assche G, Schnitzler F, Arijs I, De Hertogh G, Hoffman I, Geboes JK, Rutgeerts P. Ferrante M, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2007 Feb;13(2):123-8. doi: 10.1002/ibd.20054. Inflamm Bowel Dis. 2007. PMID: 17206703 Clinical Trial.

6

Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.

Ferrante M, Declerck S, De Hertogh G, Van Assche G, Geboes K, Rutgeerts P, Penninckx F, Vermeire S, D'Hoore A. Ferrante M, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2008 Jan;14(1):20-8. doi: 10.1002/ibd.20278. Inflamm Bowel Dis. 2008. PMID: 17973304

7

What is the role of endoscopy in predicting Crohn's disease relapse or course?

Rutgeerts P, Vermeire S, Van Assche G. Rutgeerts P, et al. Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S183-4. doi: 10.1002/ibd.20721. Inflamm Bowel Dis. 2008. PMID: 18816677 No abstract available.

8

What can we expect from endoscopic dilation of the stenotic tract in Crohn's disease?

Van Assche G, Vermeire S, Rutgeerts P. Van Assche G, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S275-6. doi: 10.1002/ibd.20648. Inflamm Bowel Dis. 2008. PMID: 18816706 No abstract available.

9

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.

Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P. Schnitzler F, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2009 Sep;15(9):1295-301. doi: 10.1002/ibd.20927. Inflamm Bowel Dis. 2009. PMID: 19340881

10

Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series.

Ferrante M, D'Haens G, Dewit O, Baert F, Holvoet J, Geboes K, De Hertogh G, Van Assche G, Vermeire S, Rutgeerts P; Belgian IBD Research Group. Ferrante M, et al. Among authors: rutgeerts p. Inflamm Bowel Dis. 2010 Feb;16(2):243-9. doi: 10.1002/ibd.21037. Inflamm Bowel Dis. 2010. PMID: 19637335 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

727 results

Search Page